Link
The Overlooked Issue of Shingles Infections in Older Canadians, and How to Address It!
Organization: National Institute on AgeingPublished: 2022
"Based on the prevalence of shingles in older adults, the costs to health systems in managing the disease, and the patchwork of vaccination coverage provincially and territorially, there is additional work to be done to improve the prevention of shingles in Canada. The NIA has developed eight evidence informed policy recommendations and practice approaches that can be used by health authorities and organizations to support vaccination efforts and increase overall prevention of shingles across Canada." - The Overlooked Issue of Shingles Infections in Older Canadians, And How to Address It!
Resource Group:
Implementation Tool
Product Type: Report
Vaccine Acceptance and Uptake
Understanding Vaccine Acceptance and Uptake
Non-Publicly Funded Vaccines
Monitoring and Surveillance
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Vaccine Preventable Diseases
Communicable Diseases
Herpes Zoster (Shingles)
Product Type: Report
Category:
Vaccination Decision Making,Vaccine Acceptance and Uptake,Understanding Vaccine Acceptance and Uptake,Non-Publicly Funded Vaccines,Monitoring and Surveillance,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals,Vaccine Preventable Diseases,Communicable Diseases,Herpes Zoster (Shingles) Vaccination Decision MakingVaccine Acceptance and Uptake
Understanding Vaccine Acceptance and Uptake
Non-Publicly Funded Vaccines
Monitoring and Surveillance
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Vaccine Preventable Diseases
Communicable Diseases
Herpes Zoster (Shingles)
Audience:
Health Care Professional
Policy Makers
Population: Seniors
Healthcare Personnel
Region: National
Policy Makers
Population: Seniors
Healthcare Personnel
Region: National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.